Journal: Biochemical Journal
Article Title: TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells
doi: 10.1042/BCJ20220314
Figure Lengend Snippet: ( A ) Representative image of spleens of 12 week old WT and TAK1[D175A] × Vav-iCre mice (D175A), scale bar = 1 cm. ( B ) Spleen weights of 12 week old WT ( n = 4) and TAK1[D175A] × Vav-iCre mice ( n = 4). Each symbol represents an individual mouse. ( C – E ) As in ( B ) except that splenocyte ( C ), B cell ( D ) and neutrophil ( E ) numbers in the spleen are shown. ( F ) Representative images of axillary (upper panel) and inguinal (lower panel) lymph nodes (LN) of 12 week old WT and TAK1[D175A] × Vav-iCre mice (D175A). ( G ) Total cell numbers in axillary and inguinal LN of 12 week old WT ( n = 4) and TAK1[D175A] × Vav-iCre mice ( n = 4). ( H ) As in ( G ), except B cell numbers in the LN are shown. Statistical significance between the two genotypes was calculated using the unpaired t -test with Welch's correction; * denotes P < 0.05. ( I ) Extracts of BMDM (10 µg protein) from three separate WT mice or three separate TAK1[D175A] × Vav-iCre mice (D175A) (+,+,+) were denatured in SDS, subjected to SDS–PAGE, transferred to PVDF membranes and immunoblotted using the ECL detection system (GE Healthcare) with antibodies recognising TAK1, TAB1, TAB2, TAB3 and GAPDH as a loading control.
Article Snippet: The TAK1 inhibitor NG-25 was synthesised by Dr Natalia Shpiro, MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, and 5Z-7-oxozeaenol was purchased from Tocris (#3604).
Techniques: SDS Page, Control